It shows great potential as a prospective anticancer agent due to its ability to induce apoptosis, inhibit angiogenesis, and modulate crucial signaling pathways involved in cancer development and progression, such as the NF-κB pathway, Janus kinase/signal transducer and activator of transcription 3 (JAK-STAT3), pathway and Phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. The gene discussed is MTOR; the disease is cancer.